From Diagnosis to Recovery: Ulcerative Colitis Specialists in Catonsville MD

At Nasseri Clinic of Arthritic and Rheumatic Diseases, we understand that autoimmune and inflammatory conditions can affect various organs—including the gastrointestinal tract. Infusion therapy, a service offered at our clinic, plays a crucial role in controlling inflammation for patients with conditions such as ulcerative colitis—a chronic inflammatory bowel disease that affects the colon and rectum.
 
Our clinic specializes in the administration of advanced infusion therapies, including biologic medications. These biologic drugs are designed to target specific components of the immune system that drive inflammation. For example, some biologics block tumor necrosis factor-alpha (TNF-alpha), a protein that promotes inflammation in the digestive tract. By neutralizing TNF-alpha or other inflammatory molecules, these medications help reduce the abnormal immune response that causes tissue damage in the colon lining.
 
Receiving these medications through intravenous (IV) infusion allows for faster and more effective delivery compared to oral medications. Under the supervision of our experienced medical team, patients benefit from a targeted approach that reduces the severity and frequency of ulcerative colitis symptoms such as abdominal pain, diarrhea, and rectal bleeding. Infusion therapy can also promote healing of the colon lining, reduce the risk of complications, and improve overall quality of life.
 
At Nasseri Clinic, patient safety and comfort are our top priorities. We provide regular monitoring and support throughout the infusion process to ensure the therapy’s effectiveness and to manage any potential side effects. Our goal is to help patients achieve better control over their disease, minimize the need for corticosteroids, and lower the risk of flare-ups and hospitalizations.

At Nasseri Clinic of Arthritic and Rheumatic Diseases, we understand that ulcerative colitis—an inflammatory bowel disease with strong autoimmune features—often overlaps with other rheumatic and systemic conditions. Our approach to treating ulcerative colitis is highly individualized and grounded in our extensive experience managing complex autoimmune and inflammatory diseases.
 
When a patient presents with ulcerative colitis, our rheumatology team conducts a comprehensive assessment, including a detailed medical history, thorough physical examination, and, when appropriate, advanced diagnostic testing. We pay special attention to identifying extra-intestinal manifestations such as arthritis, joint pain, or other autoimmune symptoms that frequently accompany ulcerative colitis and can impact a patient’s overall health.
 
Our multidisciplinary team collaborates to develop a treatment plan tailored to each patient’s unique needs. For patients with mild disease, we may utilize anti-inflammatory medications and immune-modulating therapies that target both bowel and joint inflammation. In moderate to severe cases, we consider advanced immunosuppressive or biologic agents that have proven efficacy in both ulcerative colitis and associated rheumatic conditions, always balancing the potential benefits and risks.
 
Recognizing the importance of whole-person care, we also offer nutritional counseling and psychological support. Our providers help patients identify dietary triggers and design meal plans that support gut and joint health, while our behavioral health specialists provide support for the emotional challenges that can accompany chronic autoimmune diseases.
 
For patients whose ulcerative colitis does not respond to medical management, we coordinate closely with surgical specialists to explore advanced surgical options, ensuring that decisions are made in partnership with patients and their families.
 
Ongoing follow-up and disease monitoring are hallmarks of care at Nasseri Clinic. By maintaining regular contact and adapting treatment as symptoms evolve, we strive to achieve optimal control of both ulcerative colitis and any related rheumatic manifestations—improving quality of life and long-term outcomes for our patients.

At Nasseri Clinic of Arthritic and Rheumatic Diseases, we recognize that many conditions we treat—such as inflammatory arthritis and certain autoimmune diseases—can also be associated with gastrointestinal manifestations, including ulcerative colitis. Injectable biologic medications, such as infliximab, adalimumab, or golimumab, are commonly prescribed for both rheumatic diseases and ulcerative colitis due to their ability to target underlying immune system dysfunction.
 
For patients who are prescribed these biologic treatments for ulcerative colitis, you can generally expect to start noticing improvement within two to six weeks following the initial dose. However, the exact timeframe can vary depending on the medication selected, the severity of your condition, and your individual response to therapy. In some cases, it may take up to twelve weeks or longer to achieve significant or sustained benefits.
 
It is important to continue your injectable treatment as directed and maintain regular follow-up appointments at Nasseri Clinic. Our healthcare team will closely monitor your progress and work with you to manage any side effects. If you do not experience the expected improvement within the recommended timeframe, we may discuss adjusting your treatment plan or exploring alternative options to achieve the best possible outcomes for your health.

At Nasseri Clinic of Arthritic and Rheumatic Diseases, we offer advanced infusion and biologic therapies to help manage moderate to severe ulcerative colitis (UC). With Dr. Nasser Nasseri’s expertise, patients benefit from the clinic’s Jean Walter Infusion Center, where the safe and efficient delivery of cutting-edge biologic medications is central to UC management.

These specialized treatments are designed to target the immune system’s inflammatory processes directly, using medications such as:

• Infliximab (Remicade)
• Vedolizumab (Entyvio)
• Ustekinumab (Stelara)

Dr. Nasseri often recommends infusion therapy for patients who have not responded well to oral medications, providing rapid delivery of potent anti-inflammatory agents directly into the bloodstream for maximum effect.

Our comprehensive on-site radiology and lab services allow for accurate monitoring of disease activity and evaluation of treatment effectiveness, ensuring your progress is carefully tracked.

By combining Dr. Nasseri’s specialized care with robust infusion capabilities, we offer a focused, convenient approach to UC management—aiming to reduce inflammation, prevent tissue damage, and improve your overall quality of life. For more information, contact us or book an appointment online. We are conveniently located at 700 Geipe Rd, Suite 200B, Catonsville, MD 21228. We serve patients from Catonsville MD, Hebbville MD, Woodlawn MD, Arbutus MD, Ellicott City MD, and surrounding areas.